Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.
about
Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.P53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosisMetalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes.A novel recombinant anti-epidermal growth factor receptor peptide vaccine capable of active immunization and reduction of tumor volume in a mouse model.Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion.Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme.
P2860
Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Anti-EGFR monoclonal antibodie ...... in to EGFR-expressing tumours.
@en
type
label
Anti-EGFR monoclonal antibodie ...... in to EGFR-expressing tumours.
@en
prefLabel
Anti-EGFR monoclonal antibodie ...... in to EGFR-expressing tumours.
@en
P2093
P2860
P1476
Anti-EGFR monoclonal antibodie ...... in to EGFR-expressing tumours.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0215(19980119)75:2<310::AID-IJC22>3.0.CO;2-F
P577
1998-01-01T00:00:00Z